A Curve‐Free Method for Phase I Clinical Trials (Q4667490): Difference between revisions

From MaRDI portal
Created claim: Wikidata QID (P12): Q52076810, #quickstatements; #temporary_batch_1711574657256
Set OpenAlex properties.
 
(One intermediate revision by one other user not shown)
Property / cites work
 
Property / cites work: Tailfree and neutral random probabilities and their posterior distributions / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Bayesian nonparametric approach to determining a maximum tolerated dose / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: On the distribution of the product of independent beta random variables / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1111/j.0006-341x.2000.00609.x / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2080277472 / rank
 
Normal rank

Latest revision as of 08:59, 30 July 2024

scientific article; zbMATH DE number 2159529
Language Label Description Also known as
English
A Curve‐Free Method for Phase I Clinical Trials
scientific article; zbMATH DE number 2159529

    Statements

    A Curve‐Free Method for Phase I Clinical Trials (English)
    0 references
    0 references
    0 references
    0 references
    20 April 2005
    0 references
    continual reassessment method
    0 references
    dose-finding studies
    0 references
    maximum tolerated dose
    0 references
    neutral to the right process
    0 references
    phase I clinical trial
    0 references
    product-of-beta priors
    0 references
    toxicity
    0 references

    Identifiers